Dent Neurologic

Pediatric Neurology Center

Mohammad M. Qasaymeh, MD, MS

Center Director

Research Trial Information

“Learn more about The AbbVie PERISCOPE Study (also known as the 3110-305-002 Study), evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.”

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Scroll to Top